BAX and colon carcinoma: In contrast to bortezomib, b-AP15 induces cell death independently of Bcl-2, Bax and Bak, exhibits anti-tumor activity in solid tumor models and shows greatest activity towards colon carcinoma and CNS lineage cells [17], [48].